We have data on 76 companies that use OncoMED. The companies using OncoMED are most often found in United States and in the Pharmaceuticals industry. OncoMED is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for OncoMED usage goes back as far as 5 years and 11 months.
|Company||Nomura Holdings, Inc.|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, OncoMED has a market share of about 0.1%. Other major and competing products in this category include:
OncoMed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics that address the fundamental biology driving cancer's growth, resistance, recurrence and metastasis.
Looking at OncoMED customers by industry, we find that Pharmaceuticals (20%), Hospital & Health Care (19%), Biotechnology (11%) and Higher Education (7%) are the largest segments.
62% of OncoMED customers are in United States and 9% are in Brazil.
Of all the customers that are using OncoMED, a majority (52%) are large (>1000 employees), 15% are small (<50 employees) and 23% are medium-sized.
Of all the customers that are using OncoMED, 41% are small (<$50M), 0% are medium-sized and 43% are large (>$1000M).